Consumer Health COVID19
Chiropractors, Researchers Begin the Hunt for Long COVID Therapy
Leading clinical chiropractic physicians, including those who have experienced in managing WFH pain for COVID-19, are collecting early data with researcher...
April 25, 2022 | News
Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine
Data from this combination trial will inform planned Phase 2 dose confirmation trial, scheduled to begin by the end of 2022 Immune response confirmed in...
April 22, 2022 | News
Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...
April 20, 2022 | News
Novavax and SII Receive EUA for Novavax' COVID-19 Vaccine in Thailand
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectiou...
April 11, 2022 | News
New very-high-sensitivity rapid antigen test kits hit Australian market
Medriva; https://medriva.com, a leading global manufacturer of COVID-19 testing and vaccination products, announced the Australian availability ...
April 08, 2022 | News
Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark
Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu Assay result of Seegene's decades-long know-how, applies D...
April 07, 2022 | News
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China
Pre-clinical trial results showed that CanSinoBIO's COVID-19 mRNA vaccine can induce high-titer neutralizing antibody levels against multiple SARS-CoV-2 va...
April 05, 2022 | News
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China
Pre-clinical trial results showed that CanSinoBIO's COVID-19 mRNA vaccine can induce high-titer neutralizing antibody levels against multiple SARS-CoV-2 va...
April 04, 2022 | News
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the EU to Adolescents (Ages 12-17)
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...
April 01, 2022 | News
Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...
March 28, 2022 | News
iMeddy provides free video medical consultation to COVID-19 patients
The service is being carried out in two phases. The first phase, which is now complete, targeted low-income families, while the upcoming second phase will ...
March 25, 2022 | News
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia
The MOH Malaysia recommends using Convidecia™ as a heterologous booster for individuals aged 18 and above who have been administered two doses of ina...
March 23, 2022 | News
Novavax and SII Announce First EUA of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India
Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorized&n...
March 23, 2022 | News
Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules
These experimental results show that Lianhua Qingwen Capsules have significant inhibiting effect on the cytopathic effect induced by Omicron variant so as ...
March 22, 2022 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
